Association Between SGLT2 Inhibitor Therapy and the Incidence of Tinnitus in Patients with Type 2 Diabetes: A Retrospective Cohort Study
There was no difference in tinnitus incidence between patients with SGLT2 or DPP4 inhibitors. The causes could lie in the heterogeneous, not purely vascular, etiology of tinnitus in general practitioners' practices. Future studies should include further clinical data, including confirmed hearing impairments.
Authors
- Karel Kostev (ORCID: https://orcid.org/0000-0002-2124-7227)
- Simon Bode
- D Seidel
Institutions
- Philipps University of Marburg (DE)
- Kreiskrankenhaus Gummersbach (DE)
Publication Details
- Journal
- Audiology Research
- Published
- 2025-08-09
- DOI
- https://doi.org/10.3390/audiolres15040102
- Primary Topic
- Ion Channels and Receptors
- Type
- article
- Field-Weighted Citation Impact
- 0.00